EP
GWPH

Elkhorn Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Elkhorn Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-995
Closed -$97K – 45
2020
Q3 		$97K Buy
+995
New +$115K 0.08% 29

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Elkhorn Partners's GWPH Position: Q4 2020 in Review

Elkhorn Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 995 shares — an estimated $97K sold.

Elkhorn Partners first reported a position in GWPH in Q3 2020 and held it in 1 quarter. The position peaked at $97K in Q3 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Elkhorn Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Elkhorn Partners sold 995 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $97K.
  • Elkhorn Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • Elkhorn Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $97K in Q3 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Elkhorn Partners's 13F filing for Q4 2020, filed 12 Feb 2021.